Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma

European Urology

Volumn 66, Issue 2, 2014, Pages 379-385

  Lee, Daniel J ^a   Xylinas, Evanguelos ^a,b,c   Rieken, Malte ^a,d   Khani, Francesca ^a   Klatte, Tobias ^e   Wood, Christopher G ^f   Karam, Jose A ^f   Weizer, Alon Z ^g   Raman, Jay D ^h   Remzi, Mesut ^e   Guo, Charles C ^f   Rioux Leclercq, Nathalie ⁱ   Haitel, Andrea ^e   Bolenz, Christian ^j   Bensalah, Karim ⁱ   Sagalowsky, Arthur I ^k   Montorsi, Francesco ^l   Lotan, Yair ^k   Shariat, Shahrokh F ^e   Robinson, Brian D ^a   Margulis, Vitaly ^k   more..

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b INSERM   (France)

^c Institut Cochin   (France)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

ⁱ UNIVERSITÉ DE RENNES 1   (France)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^l VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

more..

Author keywords

Biomarker; Disease recurrence; Immunohistochemistry; IMP 3; Outcomes; Prognosis; Survival; Upper tract urothelial carcinoma

Indexed keywords

INSULIN LIKE GROWTH FACTOR MESSENGER RNA BINDING PROTEIN 3; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; IMP3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROURETERECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; CARCINOMA; CHEMISTRY; CLINICAL TRIAL; DISEASE FREE SURVIVAL; KIDNEY TUMOR; MIDDLE AGED; MULTICENTER STUDY; NEPHRECTOMY; PATHOLOGY; SURGERY; SURVIVAL RATE; TUMOR RECURRENCE; URETER; URETER TUMOR; UROTHELIUM;

AGED; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; RETROSPECTIVE STUDIES; RNA-BINDING PROTEINS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; URETER; URETERAL NEOPLASMS; UROTHELIUM;

EID: 84904070228     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.12.008     Document Type: Article

References (30)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. M.C. Hall, S. Womack, A.I. Sagalowsky, T. Carmody, M.D. Erickstad, and C.G. Roehrborn Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients Urology 52 1998 594 601
3. R.E. Hautmann, R.C. de Petriconi, C. Pfeiffer, and B.G. Volkmer Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients Eur Urol 61 2012 1039 1047
4. S.F. Shariat, P.I. Karakiewicz, and G.S. Palapattu et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium J Urol 176 2006 2414 2422 discussion 2422
5. M. Rouprêt, M. Babjuk, and E. Comperat et al. European guidelines on upper tract urothelial carcinomas: 2013 update Eur Urol 63 2013 1059 1071
6. D.A. Green, M. Rink, and E. Xylinas et al. Urothelial carcinoma of the bladder and the upper tract: disparate twins J Urol 189 2012 1214 1221
7. L.M. Krabbe, A. Bagrodia, and Y. Lotan et al. Prospective analysis of Ki-67 is an independent predictor of oncological outcomes in patients with high-grade upper tract urothelial carcinoma: results of a prospective analysis and a review of the literature J Urol 191 2014 28 34
8. L. Sitnikova, G. Mendese, and Q. Liu et al. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder Clin Cancer Res 14 2008 1701 1706
9. T. Szarvas, F. vom Dorp, and C. Niedworok et al. High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer BJU Int 110 2012 E308 E317
10. M. Rink, E.K. Cha, and D. Green et al. Biomolecular predictors of urothelial cancer behavior and treatment outcomes Curr Urol Rep 13 2012 122 135
11. M. Rink, H. Fajkovic, and E.K. Cha et al. Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma Eur Urol 61 2012 854 855
12. V. Margulis, S.F. Shariat, and S.F. Matin et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration Cancer 115 2009 1224 1233
13. J.C. Messer, J.D. Terrell, and M.P. Herman et al. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma Urol Oncol 31 2011 904 908
14. M. Rouprêt, V. Hupertan, and T. Seisen et al. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis J Urol 189 2013 1662 1669
15. E.K. Cha, S.F. Shariat, and M. Kormaksson et al. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma Eur Urol 61 2012 818 825
16. D.R. Yates, V. Hupertan, and P. Colin et al. Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram Br J Cancer 106 2012 1083 1088
17. A.O. Gure, R. Chua, and B. Williamson et al. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer Clin Cancer Res 11 2005 8055 8062
18. D. Perez, F. Hauswirth, and D. Jager et al. Protein expression of cancer testis antigens predicts tumor recurrence and treatment response to imatinib in gastrointestinal stromal tumors Int J Cancer 128 2010 2947 2952
19. S.F. Shariat, D.C. Chade, and P.I. Karakiewicz et al. Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer J Urol 183 2009 68 75
20. S.F. Shariat, A.R. Zlotta, R. Ashfaq, A.I. Sagalowsky, and Y. Lotan Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness Mod Pathol 20 2007 445 459
21. E. Xylinas, M. Rink, and V. Margulis et al. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy BJU Int 112 2013 453 461
22. A.S. Alva, S.F. Matin, S.P. Lerner, and A.O. Siefker-Radtke Perioperative chemotherapy for upper tract urothelial cancer Nat Rev Urol 9 2012 266 273
23. N.J. Hellenthal, S.F. Shariat, and V. Margulis et al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration J Urol 182 2009 900 906
24. M. Vassilakopoulou, T. de la Motte Rouge, and P. Colin et al. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study Cancer 117 2011 5500 5508
25. F. Audenet, D.R. Yates, O. Cussenot, and M. Rouprêt The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC) Urol Oncol 31 2010 407 413
26. E. Xylinas, E.K. Cha, and M. Sun et al. Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling Br J Cancer 107 2012 1826 1832
27. A.J. Birtle, R. Lewis, M. Johnson, and E. Hall Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC) - opening of the peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) trial BJU Int 110 2012 919 921
28. J.L. Bell, K. Wachter, and B. Muhleck et al. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci 70 2012 2657 2675
29. K. Kono, Y. Mizukami, and Y. Daigo et al. Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer Cancer Sci 100 2009 1502 1509
30. E. Xylinas, E.K. Cha, and F. Khani et al. Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder J Urol 191 2014 830 841